Delirium

Delirium is acute global confusion — disorientation to time, place, and person, combined with agitation and severely impaired cognition.

As a drug effect it is high-dose-only and acute, resolving as the substance wears off, which sets it apart from clinical delirium with its medical causes and open-ended duration. It ranges from confused disorientation to complete loss of contact with reality, and at its most severe carries a real risk of injury or death.

Delirium is rare across psychoactive substances but well-documented at toxic doses. It is most commonly induced at high doses under deliriants such as diphenhydramine, datura, and benzydamine, and under depressants like alcohol, eszopiclone, and promethazine; it also appears at extreme doses under stimulants such as MDMA, 3-MMC, and 4-FA, and occasionally under psychedelics such as psilocybin mushrooms.

Delirium is felt as a complete collapse of coherent thought: the person cannot track where they are, what time it is, or what is happening around them. Hallucinations — typically mundane, convincing scenes rather than geometric patterns — are indistinguishable from reality.

It commonly comes with physical agitation, picking at phantom objects, fragmented or mumbling speech, and a racing heart. Unlike psychedelic confusion, the person typically has no awareness that anything is wrong. At high doses under deliriants, all coherent interaction breaks down entirely and cannot be talked through.

Delirium arises through different pathways depending on the drug class:

• Deliriants — block muscarinic acetylcholine receptors throughout the brain; the resulting cholinergic deficit produces the hallmark confusion, convincing hallucinations, and agitation.
• Depressants — at toxic doses, alcohol, eszopiclone, and promethazine produce profound CNS depression that disrupts orientation and coherent cognition.
• Stimulants — at extreme doses, MDMA, 3-MMC, and 4-FA can cross into delirium through monoaminergic overactivation, hyperthermia, and serotonin toxicity.
• Psychedelics — rarely, at very high doses, psilocybin mushrooms can produce delirium-like disorientation that goes beyond ordinary psychedelic confusion.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Dose is the dominant factor — delirium is almost exclusively a high-dose phenomenon, and the threshold rises steeply with lower amounts. Sleep deprivation, dehydration, and prior neurological conditions lower the threshold, especially under deliriants and depressants.

A personal history of psychosis raises risk substantially. Unlike anxiety, delirium is not driven by expectation and cannot be mitigated by mindset alone. Combining drug classes — particularly deliriants with alcohol or stimulants — sharply raises the likelihood of crossing into it.